BioNTech SE (BNTX)
101.98
+0.37
(+0.36%)
USD |
NASDAQ |
Sep 01, 16:00
101.99
+0.01
(+0.01%)
After-Hours: 17:23
BioNTech Total Long Term Debt (Quarterly) : 349.05M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 349.05M |
| March 31, 2026 | 348.89M |
| December 31, 2025 | 305.59M |
| September 30, 2025 | 272.84M |
| June 30, 2025 | 302.15M |
| March 31, 2025 | 316.50M |
| December 31, 2024 | 263.22M |
| September 30, 2024 | 271.98M |
| June 30, 2024 | 272.87M |
| March 31, 2024 | 255.20M |
| December 31, 2023 | 242.03M |
| September 30, 2023 | 171.41M |
| June 30, 2023 | 182.31M |
| Date | Value |
|---|---|
| March 31, 2023 | 187.30M |
| December 31, 2022 | 226.47M |
| September 30, 2022 | 232.18M |
| June 30, 2022 | 215.99M |
| March 31, 2022 | 172.91M |
| December 31, 2021 | 226.87M |
| September 30, 2021 | 310.25M |
| June 30, 2021 | 288.06M |
| March 31, 2021 | 278.08M |
| December 31, 2020 | 290.19M |
| September 30, 2020 | 205.94M |
| June 30, 2020 | 78.95M |
| March 31, 2020 | 73.12M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Moderna, Inc. | 1.266B |
| Biodexa Pharmaceuticals Plc | 0.00 |
| NuCana Plc | 0.892M |
| Mereo BioPharma Group Plc | 0.00 |
| MediGene AG | -- |